OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · IEX Real-Time Price · USD
1.480
-0.010 (-0.67%)
Mar 28, 2024, 12:45 PM EDT - Market open

OKYO Pharma Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Year 2022202120202019
Net Income
-13.27-5.43-3.35-1.54
Depreciation & Amortization
000.010.01
Share-Based Compensation
1.271.720.540.04
Other Operating Activities
4.3-1.761.20.3
Operating Cash Flow
-7.7-5.47-1.6-1.2
Capital Expenditures
-0.01-0-0.010
Acquisitions
00-0.01-0.13
Investing Cash Flow
-0.01-0-0.02-0.13
Share Issuance / Repurchase
7.322.150.250.99
Debt Issued / Paid
207.580.49
Other Financing Activities
----0.52
Financing Cash Flow
9.322.157.830.96
Net Cash Flow
1.62-3.326.21-0.37
Free Cash Flow
-7.7-5.47-1.61-1.2
Free Cash Flow Per Share
-0.27-0.25-0.07-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).